Tag
Consumer demand for expensive diabetes and weight loss medications like Ozempic could drive up insurance premiums and Medicare costs.
Despite recent reforms, journalists still need to be diligent about covering the evidence on which accelerated approvals are often based.
The FDA granted full clinical approval to Leqembi (lecanemab) on Thursday, July 6, making it only the second new drug…
The news that Highmark, a Pittsburgh-based large commercial insurer, plans to expand its coverage of several prescription digital therapeutics cleared by the…
Congress has a chance in September to try to speed the pace of studies needed to confirm whether drugs sold…
The cost of naloxone has risen sharply for people lacking insurance, even as laws have made it easier to prescribe…
Rapid antigen tests are now the standard way for people to determine if they have COVID-19, but studies show they…
The Food and Drug Administration (FDA) announced last week a series of steps meant to address long-standing concerns about breast…
Part two of two parts; the first ran Thursday, June 10. There’s still a great deal we don’t yet understand…
Part one of two parts; the second runs tomorrow, Friday, June 11. You might think that the first new drug…